In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii in Singapore
about
The Mode of Inhibitor Binding to Peptidyl-tRNA Hydrolase: Binding Studies and Structure Determination of Unbound and Bound Peptidyl-tRNA Hydrolase from Acinetobacter baumanniiCarbapenem Resistance in Gram-Negative Bacteria: The Not-So-Little Problem in the Little Red DotUsing an Adenosine Triphosphate Bioluminescent Assay to Determine Effective Antibiotic Combinations against Carbapenem-Resistant Gram Negative Bacteria within 24 HoursFrom Bench-Top to Bedside: A Prospective In Vitro Antibiotic Combination Testing (iACT) Service to Guide the Selection of Rationally Optimized Antimicrobial Combinations against Extensively Drug Resistant (XDR) Gram Negative Bacteria (GNB)Antibiotic susceptibility and molecular epidemiology of Acinetobacter calcoaceticus-baumannii complex strains isolated from a referral hospital in northern Vietnam.Novel rate-area-shape modeling approach to quantify bacterial killing and regrowth for in vitro static time-kill studies.Extensively drug-resistant Acinetobacter baumannii in a Thai hospital: a molecular epidemiologic analysis and identification of bactericidal Polymyxin B-based combinations.Assessment of minocycline and polymyxin B combination against Acinetobacter baumannii.Assessment of combination therapy in BALB/c mice injected with carbapenem-resistant Enterobacteriaceae strainsMultiple Genetic Mutations Associated with Polymyxin Resistance in Acinetobacter baumanniiOptimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosaClinical Efficacy of Polymyxin Monotherapy versus Nonvalidated Polymyxin Combination Therapy versus Validated Polymyxin Combination Therapy in Extensively Drug-Resistant Gram-Negative Bacillus Infections.Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review.In vitro activity of colistin in antimicrobial combination against carbapenem-resistant Acinetobacter baumannii isolated from patients with ventilator-associated pneumonia in VietnamTigecycline: Alone or in combination?Resurgence of Polymyxin B for MDR/XDR Gram-Negative Infections: An Overview of Current Evidence.NLRP3 inflammasome pathway has a critical role in the host immunity against clinically relevant Acinetobacter baumannii pulmonary infection.Invitro Activities of Polymyxins and Rifampicin against Carbapenem Resistant Acinetobacter baumannii at a Tertiary Care Hospital from South India.In vitro pharmacodynamics of polymyxin B and tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii.Antibiotic resistance of pathogenic Acinetobacter species and emerging combination therapy.Acinetobacter spp. Infections in Malaysia: A Review of Antimicrobial Resistance Trends, Mechanisms and Epidemiology.Genetic characterization and in vitro activity of antimicrobial combinations of multidrug-resistant Acinetobacter baumannii from a general hospital in China.Polymyxin B in Combination with Enrofloxacin Exerts Synergistic Killing against Extensive Drug-resistant Pseudomonas aeruginosa.
P2860
Q27679042-22382542-E8BD-4F7D-81BC-C4DD470529B5Q28069802-59195495-0476-4C28-A806-281A827880C1Q28391044-FE067ABB-20B9-42A6-B7B7-417018036223Q28552767-3392CCB5-BE25-4ADC-AF26-B3A1114757A4Q34732275-3A4B2823-5B25-4427-B4C5-2EEF81C9854BQ34922570-C2F39EF8-64C5-4804-A254-FB6168C715F6Q35041371-1865ED34-9ED0-402E-A045-51A144172785Q35385769-C3BFED4D-15CE-4C89-88C0-4CEE7C54DB83Q36097659-7E4430EA-91C4-42E9-A569-6D14593C0D2CQ36290637-2056FFDC-A3FF-432E-B1E3-A0BEBC8A7A11Q36887819-10D99A73-9317-4128-BCC8-DE8FA5D85D4FQ37023227-B6465A13-FF4D-4C57-827E-389CFC349C5FQ38212031-B42777C9-4FF9-4B28-816D-815C614DE16AQ38495174-77D27831-0AF1-4298-885A-0BACC92E8219Q39916184-9C9F1338-AAAF-4824-96F3-D7654B3C43C1Q40111993-2A6344B9-D51C-476D-B1C4-913B4E0A6AAAQ40160686-092EDCAB-31ED-4778-8A49-6E05F81C0A08Q40478475-9321103D-7D65-4D6E-BA04-BED3B881D6DFQ41833657-EE2F4C8F-49A4-4EAC-B706-07F788D79BD7Q46273551-0A8A0C90-725A-4FC2-AC0D-800976DFB173Q47194278-C8E38A61-19F6-4B1D-9AAF-0E8D45596205Q50053576-2A390ACE-7BF6-4A87-9053-B9E3217C50F2Q52597958-97967AF8-3001-4B38-A0D4-022A07E4F94C
P2860
In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii in Singapore
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
In-vitro activity of polymyxin ...... obacter baumannii in Singapore
@ast
In-vitro activity of polymyxin ...... obacter baumannii in Singapore
@en
In-vitro activity of polymyxin ...... obacter baumannii in Singapore
@nl
type
label
In-vitro activity of polymyxin ...... obacter baumannii in Singapore
@ast
In-vitro activity of polymyxin ...... obacter baumannii in Singapore
@en
In-vitro activity of polymyxin ...... obacter baumannii in Singapore
@nl
prefLabel
In-vitro activity of polymyxin ...... obacter baumannii in Singapore
@ast
In-vitro activity of polymyxin ...... obacter baumannii in Singapore
@en
In-vitro activity of polymyxin ...... obacter baumannii in Singapore
@nl
P2093
P2860
P921
P3181
P1433
P1476
In-vitro activity of polymyxin ...... obacter baumannii in Singapore
@en
P2093
Andrea L Kwa
S Sasikala
Thean-Yen Tan
Thuan-Tong Tan
Tze-Peng Lim
Winnie Lee
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0018485
P407
P50
P577
2011-04-21T00:00:00Z